Vanguard Group’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,461,975
Closed -$11.9M 4121
2020
Q1
$11.9M Buy
2,461,975
+96,901
+4% +$469K ﹤0.01% 2533
2019
Q4
$25.1M Buy
2,365,074
+137,029
+6% +$1.46M ﹤0.01% 2420
2019
Q3
$23.2M Buy
2,228,045
+294,590
+15% +$3.07M ﹤0.01% 2416
2019
Q2
$29.6M Buy
1,933,455
+237,768
+14% +$3.64M ﹤0.01% 2345
2019
Q1
$21.8M Buy
1,695,687
+376,091
+29% +$4.83M ﹤0.01% 2469
2018
Q4
$12.5M Buy
1,319,596
+41,567
+3% +$395K ﹤0.01% 2660
2018
Q3
$21.2M Buy
1,278,029
+18,487
+1% +$307K ﹤0.01% 2549
2018
Q2
$20.2M Buy
1,259,542
+148,043
+13% +$2.38M ﹤0.01% 2559
2018
Q1
$17M Buy
1,111,499
+156,242
+16% +$2.39M ﹤0.01% 2565
2017
Q4
$14.9M Buy
955,257
+74,638
+8% +$1.16M ﹤0.01% 2629
2017
Q3
$9.78M Buy
880,619
+16,851
+2% +$187K ﹤0.01% 2817
2017
Q2
$7.95M Buy
863,768
+38,615
+5% +$355K ﹤0.01% 2888
2017
Q1
$7.06M Buy
825,153
+204,228
+33% +$1.75M ﹤0.01% 2919
2016
Q4
$6.64M Buy
620,925
+26,248
+4% +$281K ﹤0.01% 2927
2016
Q3
$6.44M Buy
594,677
+67,986
+13% +$736K ﹤0.01% 2880
2016
Q2
$3.57M Buy
526,691
+19,877
+4% +$135K ﹤0.01% 3128
2016
Q1
$2.36M Buy
506,814
+36,565
+8% +$170K ﹤0.01% 3315
2015
Q4
$2.97M Buy
470,249
+11,913
+3% +$75.2K ﹤0.01% 3232
2015
Q3
$4.05M Buy
458,336
+22,723
+5% +$201K ﹤0.01% 3066
2015
Q2
$5.13M Buy
435,613
+6,659
+2% +$78.4K ﹤0.01% 3005
2015
Q1
$6.21M Buy
428,954
+120,071
+39% +$1.74M ﹤0.01% 2883
2014
Q4
$5.27M Buy
308,883
+8,453
+3% +$144K ﹤0.01% 2876
2014
Q3
$3.74M Buy
300,430
+19,982
+7% +$249K ﹤0.01% 2990
2014
Q2
$4.11M Buy
280,448
+3,310
+1% +$48.6K ﹤0.01% 2945
2014
Q1
$5.64M Buy
277,138
+73,432
+36% +$1.49M ﹤0.01% 2759
2013
Q4
$3.99M Buy
203,706
+29,350
+17% +$575K ﹤0.01% 2912
2013
Q3
$7.9M Buy
174,356
+18,863
+12% +$854K ﹤0.01% 2511
2013
Q2
$3.71M Buy
+155,493
New +$3.71M ﹤0.01% 2826